FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138404218> ?p ?o ?g. }

• W2138404218 endingPage "4423" @default.
• W2138404218 startingPage "4416" @default.
• W2138404218 abstract "The potential benefits of extended rituximab treatment have been investigated in a randomized trial comparing the standard schedule with prolonged treatment in 202 patients with newly diagnosed or refractory/relapsed follicular lymphoma (FL). All patients received standard treatment (rituximab 375 mg/m(2) weekly x 4). In 185 evaluable patients, the overall response rate was 67% in chemotherapy-naive patients and 46% in pretreated cases (P <.01). Patients responding or with stable disease at week 12 (n = 151) were randomized to no further treatment or prolonged rituximab administration (375 mg/m(2) every 2 months for 4 times). At a median follow-up of 35 months, the median event-free survival (EFS) was 12 months in the no further treatment versus 23 months in the prolonged treatment arm (P =.02), the difference being particularly notable in chemotherapy-naive patients (19 vs 36 months; P =.009) and in patients responding to induction treatment (16 vs 36 months; P =.004). The number of t(14;18)-positive cells in peripheral blood (P =.0035) and in bone marrow (P =.0052) at baseline was predictive for clinical response. Circulating normal B lymphocytes and immunoglobulin M (IgM) plasma levels decreased for a significantly longer time after prolonged treatment, but the incidence of adverse events was not increased. In patients with FL, the administration of 4 additional doses of rituximab at 8-week intervals significantly improves the EFS." @default.
• W2138404218 created "2016-06-24" @default.
• W2138404218 creator A5000513493 @default.
• W2138404218 creator A5001536238 @default.
• W2138404218 creator A5007007404 @default.
• W2138404218 creator A5013411479 @default.
• W2138404218 creator A5018701322 @default.
• W2138404218 creator A5023071102 @default.
• W2138404218 creator A5030996590 @default.
• W2138404218 creator A5032612186 @default.
• W2138404218 creator A5045311601 @default.
• W2138404218 creator A5046258011 @default.
• W2138404218 creator A5046320580 @default.
• W2138404218 creator A5047468243 @default.
• W2138404218 creator A5053052330 @default.
• W2138404218 creator A5062630040 @default.
• W2138404218 creator A5078891413 @default.
• W2138404218 creator A5082943014 @default.
• W2138404218 creator A5085404499 @default.
• W2138404218 creator A5087532681 @default.
• W2138404218 creator A5090350899 @default.
• W2138404218 date "2004-02-12" @default.
• W2138404218 modified "2023-09-26" @default.
• W2138404218 title "Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule" @default.
• W2138404218 cites W1754056873 @default.
• W2138404218 cites W1915689252 @default.
• W2138404218 cites W1921096083 @default.
• W2138404218 cites W1942856476 @default.
• W2138404218 cites W1945274657 @default.
• W2138404218 cites W1970346572 @default.
• W2138404218 cites W2008278995 @default.
• W2138404218 cites W2058015212 @default.
• W2138404218 cites W206701898 @default.
• W2138404218 cites W2087425662 @default.
• W2138404218 cites W2099314298 @default.
• W2138404218 cites W2104067910 @default.
• W2138404218 cites W2104334201 @default.
• W2138404218 cites W2104940816 @default.
• W2138404218 cites W2112476236 @default.
• W2138404218 cites W21149459 @default.
• W2138404218 cites W2116262245 @default.
• W2138404218 cites W2117677108 @default.
• W2138404218 cites W2122284431 @default.
• W2138404218 cites W2127593282 @default.
• W2138404218 cites W2148613364 @default.
• W2138404218 cites W2153230421 @default.
• W2138404218 cites W2155001516 @default.
• W2138404218 cites W2164854559 @default.
• W2138404218 cites W2167993114 @default.
• W2138404218 cites W2168750246 @default.
• W2138404218 cites W2168926834 @default.
• W2138404218 cites W2264636885 @default.
• W2138404218 cites W2266889995 @default.
• W2138404218 cites W339313837 @default.
• W2138404218 doi "https://doi.org/10.1182/blood-2003-10-3411" @default.
• W2138404218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14976046" @default.
• W2138404218 hasPublicationYear "2004" @default.
• W2138404218 type Work @default.
• W2138404218 sameAs 2138404218 @default.
• W2138404218 citedByCount "542" @default.
• W2138404218 countsByYear W21384042182012 @default.
• W2138404218 countsByYear W21384042182013 @default.
• W2138404218 countsByYear W21384042182014 @default.
• W2138404218 countsByYear W21384042182015 @default.
• W2138404218 countsByYear W21384042182016 @default.
• W2138404218 countsByYear W21384042182017 @default.
• W2138404218 countsByYear W21384042182018 @default.
• W2138404218 countsByYear W21384042182019 @default.
• W2138404218 countsByYear W21384042182020 @default.
• W2138404218 countsByYear W21384042182021 @default.
• W2138404218 countsByYear W21384042182022 @default.
• W2138404218 countsByYear W21384042182023 @default.
• W2138404218 crossrefType "journal-article" @default.
• W2138404218 hasAuthorship W2138404218A5000513493 @default.
• W2138404218 hasAuthorship W2138404218A5001536238 @default.
• W2138404218 hasAuthorship W2138404218A5007007404 @default.
• W2138404218 hasAuthorship W2138404218A5013411479 @default.
• W2138404218 hasAuthorship W2138404218A5018701322 @default.
• W2138404218 hasAuthorship W2138404218A5023071102 @default.
• W2138404218 hasAuthorship W2138404218A5030996590 @default.
• W2138404218 hasAuthorship W2138404218A5032612186 @default.
• W2138404218 hasAuthorship W2138404218A5045311601 @default.
• W2138404218 hasAuthorship W2138404218A5046258011 @default.
• W2138404218 hasAuthorship W2138404218A5046320580 @default.
• W2138404218 hasAuthorship W2138404218A5047468243 @default.
• W2138404218 hasAuthorship W2138404218A5053052330 @default.
• W2138404218 hasAuthorship W2138404218A5062630040 @default.
• W2138404218 hasAuthorship W2138404218A5078891413 @default.
• W2138404218 hasAuthorship W2138404218A5082943014 @default.
• W2138404218 hasAuthorship W2138404218A5085404499 @default.
• W2138404218 hasAuthorship W2138404218A5087532681 @default.
• W2138404218 hasAuthorship W2138404218A5090350899 @default.
• W2138404218 hasBestOaLocation W21384042181 @default.
• W2138404218 hasConcept C112758219 @default.
• W2138404218 hasConcept C124952713 @default.
• W2138404218 hasConcept C126322002 @default.
• W2138404218 hasConcept C142362112 @default.
• W2138404218 hasConcept C143998085 @default.

• next